MediWound annual r&d spending
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
MediWound R&D Spending Growth & History (MDWD)
MediWound's r&d spending was $14.3M for fiscal 2025.
View full MediWound company overviewMediWound annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $14.3M | $5.4M | +61.30% |
| 2024 | 2024-12-31 | $8.9M | $1.4M | +18.90% |
| 2023 | 2023-12-31 | $7.5M | −$2.7M | −26.66% |
| 2022 | 2022-12-31 | $10.2M | −$75,000 | −0.73% |
| 2021 | 2021-12-31 | $10.3M | $2.6M | +33.23% |
| 2020 | 2020-12-31 | $7.7M | $2.7M | +54.92% |
| 2019 | 2019-12-31 | $5.0M | $897,000 | +22.03% |
| 2018 | 2018-12-31 | $4.1M | −$1.4M | −25.45% |
| 2017 | 2017-12-31 | $5.5M | −$1.6M | −22.72% |
| 2016 | 2016-12-31 | $7.1M | $1.0M | +17.39% |
| 2015 | 2015-12-31 | $6.0M | — | — |
MediWound quarterly r&d spending
Q2.17
Q2.18
Q2.19
Q2.20
Q2.21
Q2.22
Q2.23
Q2.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.9M | $2.4M | +69.03% |
| Q1 2026 | 2026-03-31 | $5.2M | $2.3M | +79.66% |
| Q4 2025 | 2025-12-31 | $4.5M | — | — |
| Q3 2025 | 2025-09-30 | $3.5M | — | — |
| Q2 2025 | 2025-06-30 | $3.5M | $1.6M | +83.93% |
| Q1 2025 | 2025-03-31 | $2.9M | — | — |
| Q2 2024 | 2024-06-30 | $1.9M | −$126,000 | −6.23% |
| Q2 2023 | 2023-06-30 | $2.0M | −$167,000 | −7.62% |
| Q2 2022 | 2022-06-30 | $2.2M | −$465,000 | −17.51% |
| Q2 2021 | 2021-06-30 | $2.7M | $1.0M | +64.76% |
| Q2 2020 | 2020-06-30 | $1.6M | $1.4M | +837.21% |
| Q2 2019 | 2019-06-30 | $172,000 | −$1.4M | −88.80% |
| Q2 2018 | 2018-06-30 | $1.5M | −$128,000 | −7.69% |
| Q2 2017 | 2017-06-30 | $1.7M | — | — |
MediWound r&d spending trends
Over the last five fiscal years, MediWound's r&d spending increased from $7.7M to $14.3M, a change of $6.6M. The latest reported quarter, Q2 2026, shows $5.9M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review MediWound source filings ↗